Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Landgren

Showing results (291-300 of 519) with videos related to

Pageof 52
Sort By:
Thrombosis Research|January 14, 2020
Hemoglobin concentration and risk of arterial and venous thrombosis in 1.5 million Swedish and Danish blood donorsMalin Hultcrantz, Anton Modlitba, Senthil K Vasan, et al.
Blood Advances|July 1, 2025
Tocilizumab Prophylaxis for Patients with Multiple Myeloma Treated with Bispecific AntibodiesAndrew Kowalski, Jillian Lykon, Benjamin T Diamond, et al.
Obesity (Silver Spring, Md.)|June 12, 2017
Circulating Adiponectin Levels Differ Between Patients with Multiple Myeloma and its Precursor DiseaseJonathan N Hofmann, Sham Mailankody, Neha Korde, et al.
International Journal of Cancer|April 15, 2009
Population-based study of autoimmune conditions and the risk of specific lymphoid malignanciesLesley A Anderson, Shahinaz Gadalla, Lindsay M Morton, et al.
Cancer|May 16, 2013
Multidrug resistance in relapsed acute myeloid leukemia: evidence of biological heterogeneityChirayu Patel, Leif Stenke, Sudhir Varma, et al.
American Journal of Hematology|November 22, 2012
Immunoparesis and monoclonal gammopathy of undetermined significance are disassociated in advanced ageBenjamin M Cherry, Rene Costello, Adriana Zingone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Circulating serum free light chains as predictive markers of AIDS-related lymphomaOla Landgren, James J Goedert, Charles S Rabkin, et al.
Lancet (London, England)|July 20, 2020
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 studyMeletios Dimopoulos, Hang Quach, Maria-Victoria Mateos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2023
Impact of Rare Structural Variant Events in Newly Diagnosed Multiple MyelomaMonika Chojnacka, Benjamin Diamond, Bachisio Ziccheddu, et al.
British Journal of Haematology|October 19, 2007
Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiologyGraça M Dores, William F Anderson, Rochelle E Curtis, et al.
Pageof 52

Showing results (291-300 of 519) with videos related to

Sort By:
Pageof 52
Thrombosis Research|January 14, 2020
Hemoglobin concentration and risk of arterial and venous thrombosis in 1.5 million Swedish and Danish blood donorsMalin Hultcrantz, Anton Modlitba, Senthil K Vasan, et al.
Blood Advances|July 1, 2025
Tocilizumab Prophylaxis for Patients with Multiple Myeloma Treated with Bispecific AntibodiesAndrew Kowalski, Jillian Lykon, Benjamin T Diamond, et al.
Obesity (Silver Spring, Md.)|June 12, 2017
Circulating Adiponectin Levels Differ Between Patients with Multiple Myeloma and its Precursor DiseaseJonathan N Hofmann, Sham Mailankody, Neha Korde, et al.
International Journal of Cancer|April 15, 2009
Population-based study of autoimmune conditions and the risk of specific lymphoid malignanciesLesley A Anderson, Shahinaz Gadalla, Lindsay M Morton, et al.
Cancer|May 16, 2013
Multidrug resistance in relapsed acute myeloid leukemia: evidence of biological heterogeneityChirayu Patel, Leif Stenke, Sudhir Varma, et al.
American Journal of Hematology|November 22, 2012
Immunoparesis and monoclonal gammopathy of undetermined significance are disassociated in advanced ageBenjamin M Cherry, Rene Costello, Adriana Zingone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Circulating serum free light chains as predictive markers of AIDS-related lymphomaOla Landgren, James J Goedert, Charles S Rabkin, et al.
Lancet (London, England)|July 20, 2020
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 studyMeletios Dimopoulos, Hang Quach, Maria-Victoria Mateos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2023
Impact of Rare Structural Variant Events in Newly Diagnosed Multiple MyelomaMonika Chojnacka, Benjamin Diamond, Bachisio Ziccheddu, et al.
British Journal of Haematology|October 19, 2007
Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiologyGraça M Dores, William F Anderson, Rochelle E Curtis, et al.
Pageof 52